Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauthier Bouche

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
La Revue Du Praticien|September 9, 2008
[Does the duration of medical consultations have an impact on the prescription of psychotropic drugs? Cross-sectional study carried out in general practice on 2,896 procedures]Olivier Kandel, Audrey Ripault, Maud Jourdain, et al.
The Lancet. Oncology|December 3, 2020
Drug repurposing in oncologyGauthier Bouche, Craig Gedye, Lydie Meheus, et al.
Nature Cancer|February 5, 2022
Challenges and opportunities for cancer clinical trials in low- and middle-income countriesBishal Gyawali, Gauthier Bouche, Nigel Crisp, et al.
The Lancet. Oncology|May 1, 2021
Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable dataGauthier Bouche, Eric Bouffet, Liese Vandeborne, et al.
Lancet (London, England)|April 15, 2023
Drug evidence watch: a process to the benefit of public healthPan Pantziarka, Ian Roberts, Patricia Vandamme, et al.
Seminars in Cancer Biology|January 27, 2020
Repurposing drugs in oncology: From candidate selection to clinical adoptionPan Pantziarka, Ciska Verbaanderd, Isabelle Huys, et al.
Surgery|June 14, 2008
Breast cancer surgery: do all patients want to go to high-volume hospitals?Gauthier Bouche, Virginie Migeot, Simone Mathoulin-Pélissier, et al.
Ecancermedicalscience|October 6, 2015
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agentVidula Sukhatme, Gauthier Bouche, Lydie Meheus, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2022
Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trialsGauthier Bouche, Ruth Langley, Hannah Rush, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Ecancermedicalscience|February 20, 2018
Does the oncology community have a rejection bias when it comes to repurposed drugs?Bishal Gyawali, Pan Pantziarka, Sergio Crispino, et al.
La Revue Du Praticien|September 9, 2008
[Does the duration of medical consultations have an impact on the prescription of psychotropic drugs? Cross-sectional study carried out in general practice on 2,896 procedures]Olivier Kandel, Audrey Ripault, Maud Jourdain, et al.
The Lancet. Oncology|December 3, 2020
Drug repurposing in oncologyGauthier Bouche, Craig Gedye, Lydie Meheus, et al.
Nature Cancer|February 5, 2022
Challenges and opportunities for cancer clinical trials in low- and middle-income countriesBishal Gyawali, Gauthier Bouche, Nigel Crisp, et al.
The Lancet. Oncology|May 1, 2021
Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable dataGauthier Bouche, Eric Bouffet, Liese Vandeborne, et al.
Lancet (London, England)|April 15, 2023
Drug evidence watch: a process to the benefit of public healthPan Pantziarka, Ian Roberts, Patricia Vandamme, et al.
Seminars in Cancer Biology|January 27, 2020
Repurposing drugs in oncology: From candidate selection to clinical adoptionPan Pantziarka, Ciska Verbaanderd, Isabelle Huys, et al.
Surgery|June 14, 2008
Breast cancer surgery: do all patients want to go to high-volume hospitals?Gauthier Bouche, Virginie Migeot, Simone Mathoulin-Pélissier, et al.
Ecancermedicalscience|October 6, 2015
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agentVidula Sukhatme, Gauthier Bouche, Lydie Meheus, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2022
Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trialsGauthier Bouche, Ruth Langley, Hannah Rush, et al.
Pageof 7